rs1555877364
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_001849.4(COL6A2):c.2988dupG(p.Phe997ValfsTer7) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001849.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.2988dupG | p.Phe997ValfsTer7 | frameshift_variant | Exon 28 of 28 | ENST00000300527.9 | NP_001840.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Bethlem myopathy 1A Pathogenic:1
This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the COL6A2 protein. Other variant(s) that disrupt this region (p.Tyr1002*) have been determined to be pathogenic (PMID: 29419890). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has not been reported in the literature in individuals with COL6A2-related conditions. This sequence change results in a premature translational stop signal in the COL6A2 gene (p.Phe997Valfs*7). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 23 amino acids of the COL6A2 protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at